Genky DrugStores Co., Ltd.
Q3 Financial Summary for the Fiscal Year Ending June 2026 (Japanese GAAP) (Consolidated)
For the cumulative Q3 period of the fiscal year ending June 2026, net sales amounted to JPY 161.710 billion (up 9.7% YoY), operating income was JPY 8.022 billion (up 17.3% YoY), and net income attributable to owners of the parent for the quarter was JPY 5.621 billion (up 15.4% YoY).
Key Figures
- Net Sales: JPY 161,710 million (up 9.7% Year-over-Year)
- Operating Income: JPY 8,022 million (up 17.3% Year-over-Year)
- Net Income Attributable to Owners of Parent (Quarter): JPY 5,621 million (up 15.4% Year-over-Year)
AI要約
Business Overview
During the cumulative Q3 period of the fiscal year ending June 2026, net sales reached JPY 161.710 billion (up 9.7% YoY), operating income was JPY 8.022 billion (up 17.3% YoY), ordinary income totaled JPY 8.168 billion (up 15.9% YoY), and net income attributable to owners of the parent for the quarter was JPY 5.621 billion (up 15.4% YoY). Despite the impact of new store openings and closures, the company advanced its dominant area strategy and pursued low-cost operations, resulting in increased revenue and profits. By store format, "R Stores" recorded JPY 143.438 billion, "Large Stores" JPY 18.049 billion, and "Others" JPY 0.221 billion. By product category, "Food" accounted for JPY 115.127 billion, "Sundries" JPY 18.433 billion, "Cosmetics" JPY 14.815 billion, "Pharmaceuticals" JPY 12.155 billion, and "Others" JPY 1.178 billion.
Financial Position Overview and Earnings Guidance
Total assets increased by JPY 15.014 billion compared to the end of the previous consolidated fiscal year to JPY 142.340 billion, and net assets rose by JPY 5.662 billion to JPY 59.090 billion. Total liabilities increased by JPY 9.352 billion to JPY 83.250 billion compared to the end of the previous fiscal year. The equity ratio was 41.4%, remaining nearly flat compared to 41.8% for the same period last year. Shares outstanding totaled 31,031,568, up from the end of the previous term, while treasury stock decreased to 532,069 shares. The consolidated earnings forecast for the full fiscal year ending June 2026 anticipates net sales of JPY 221.2 billion (up 10.2% YoY), operating income of JPY 11.05 billion (up 14.4% YoY), and net income attributable to owners of parent of JPY 7.85 billion (up 11.1% YoY).
Net Sales Trend (Million JPY)
Operating Income Trend (Million JPY)
Net Income Attributable to Owners of Parent (Quarter) Trend (Million JPY)
Equity Ratio Trend (%)
Shares Outstanding Trend (shares)
Genky DrugStores Co., Ltd.
Company overview · Stock price · Financial data · All IR